Antibody profiling of patients with prostate cancer reveals differences in antibody signatures among disease stages
Journal for Immunotherapy of Cancer
Open Access Publication
Rights and Permissions
Potluri HK, Ng TL, Newton MA, et alAntibody profiling of patients with prostate cancer reveals differences in antibody signatures among disease stagesJournal for ImmunoTherapy of Cancer 2020;8:e001510. doi: 10.1136/jitc-2020-001510 https://jitc.bmj.com/content/8/2/e001510 Copyright 2021 The Authors This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.
Potluri, Hemanth K; Ng, Tun Lee; Newton, Michael A; Zhang, Jin; Maher, Christopher A; Nelson, Peter S; and McNeel, Douglas G, "Antibody profiling of patients with prostate cancer reveals differences in antibody signatures among disease stages." Journal for Immunotherapy of Cancer. 8, 2. e001510 (2020).